arrow
C

C. Ortez

Institut de Recerca Sant Joan de Déu
H指数:28
被引数:3,016
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Loss of DOT1L disrupts neuronal transcription and leads to a neurodevelopmental disorder

DOT1L的缺失破坏了神经元转录,并导致神经发育障碍

BRAIN
IF11.7
2025-12-010
PRE
Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics

扩展遗传性痉挛性截瘫痷的范围:脑瘫中双等位基因SPAST变异的模拟

2025-09-260
OAAI
Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease

DARS2基因的biallelic变异作为轴索型Charcot–Marie–Tooth病的全新病因

2025-08-150
OAAI
Upper limb motor function in individuals with SMA type 2: natural history and impact of therapies

2型脊髓性肌萎缩症患者上肢运动功能:自然病史及疗法影响

2025-04-090
PRE
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome
2025-02-130
OAAI
Phenotype-driven genomics enhance diagnosis in children with unresolved neuromuscular diseases (27 Sept, 10.1038/s41431-024-01699-4, 2024)
2024-12-100
PRE
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication

大量儿科人群中的脑脊液同型香草酸和5-羟吲哚乙酸; 参考区间的建立以及疾病和药物的影响

2024-09-270
PRE
Phenotype-driven genomics enhance diagnosis in children with unresolved neuromuscular diseases
2024-09-272
PRE
Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases
2024-08-010
PRE
Mutations of GEMIN5 are associated with coenzyme Q10 deficiency: long-term follow-up after treatment

GEMIN5突变与辅酶Q10缺乏症相关: 治疗后的长期随访

2024-02-058
OA
Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations
2023-09-0710
OAAI
A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy
2023-07-221
OA
Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant
2023-05-169
OAAI
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen

细胞外囊泡中的全长SMN转录本作为Nusinersen治疗的2型脊髓性肌萎缩症患者的生物标志物

2023-04-057
OAAI
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy
2023-02-172
PRE